Home/AiCuris/Jacques Dumas, PhD

JD

Jacques Dumas, PhD

Chief Scientific Officer

Therapeutic Areas

Infectious Diseases Virology

AiCuris Pipeline

Drug	Indication	Phase
Pritelivir	Refractory/Resistant Herpes Simplex Virus (HSV) in immunocompromised patients	Phase 3
AIC468	Antiviral (specific indication not stated)	Phase 1

Leadership Team at AiCuris

Chief Executive Officer (CEO)

Sabrina Kuttruff-Coqui, PhD

Chief Financial Officer (CFO)

Cynthia Wat, MD

Chief Medical Officer

Prof. Helga Rübsamen‐Schaeff, PhD

Founding CEO, Supervisory Board Member

View full AiCuris profile